From Innate Immunity to Therapeutic Potential: Evaluating Recombinant LL-37 Against Resistant Pathogens

January 23, 2026

Introduction: The Persistent Gap in Antimicrobial Development The rapid escalation of antimicrobial resistance (AMR) continues to undermine the effectiveness of conventional antibiotics, particularly against pathogens belonging to the ESKAPE group. Despite decades of antibiotic discovery, the clinical pipeline for new antibacterial agents remains limited, while resistance mechanisms evolve at an accelerating pace. This imbalance has […]

How Permeation Enhancers Enable Oral Peptide Drugs: A Molecular View from SNAC and Semaglutide

January 22, 2026

For decades, oral delivery of peptide drugs has been one of the most persistent challenges in pharmaceutical science. Peptides are intrinsically ill-suited for oral administration: they are rapidly degraded by proteases and exhibit extremely low passive permeability across epithelial membranes. While injectable formulations have enabled the clinical success of many peptide therapeutics, oral delivery remains […]

Retro-Inverted Peptides: A New Design Rule for Precision Antimycobacterial Therapy

January 15, 2026

Abstract Tuberculosis remains a global health emergency, exacerbated by the rapid rise of drug-resistant Mycobacterium tuberculosis and the inherent limitations of conventional antibiotics. Host defense peptides offer a promising alternative due to their membrane-targeting mechanisms, but their clinical potential has been constrained by poor stability and inconsistent activity. Recent research published in Nature Communications challenges […]

Elamipretide: A Mitochondria-Targeted Peptide for Cardiolipin-Focused Research

January 8, 2026

Abstract Mitochondrial dysfunction is a central pathological feature of numerous diseases, including cardiovascular disorders, neurodegeneration, metabolic syndromes, and age-related tissue decline. Elamipretide (SS-31, MTP-131) is a mitochondria-targeted tetrapeptide developed to address mitochondrial impairment through selective interaction with cardiolipin, a phospholipid essential for inner mitochondrial membrane integrity and bioenergetic function. Structurally optimized for cellular permeability and […]

Decoding Peptide Materials: How Sequence Context Shapes Supramolecular Assembly

December 31, 2025

Abstract Peptide-based materials have emerged as a versatile platform for designing functional and adaptive soft matter, yet their self-assembly behavior often defies simple design rules. Traditional approaches that classify peptides by hydrophobicity, charge, or secondary-structure motifs frequently fail to predict material outcomes. Recent advances reveal that peptide assembly is governed by a context-dependent assembly code, […]

Peptide Cancer Vaccines Revisited: Overcoming Biological Limitations Through Rational Design

December 25, 2025

Abstract Peptide-based cancer vaccines were once regarded as a promising yet ultimately unsuccessful immunotherapeutic strategy, largely due to limited clinical efficacy in early trials. However, these outcomes reflected fundamental biological and design limitations rather than intrinsic shortcomings of peptide antigens. Advances in cancer immunology have clarified the essential requirements for effective cytotoxic T lymphocyte (CTL) […]

Unlocking Bioactive Peptide Potential: How Advanced Fractionation Strategies Enhance Functionality

December 19, 2025

Abstract Bioactive peptides derived from food proteins have gained increasing attention due to their diverse health-promoting properties and expanding applications in functional foods, nutraceuticals, cosmetics, and biomedicine. However, crude protein hydrolysates often exhibit inconsistent or diluted bioactivity because they contain complex mixtures of peptides with varying structures and functions. Fractionation has therefore emerged as a […]

Targeting Collagen Quality: Cheminformatics-Designed Peptides Unlock a New Era in Anti-Aging Science

December 11, 2025

Abstract Advances in cosmetic science are increasingly driven by a deeper understanding of skin biology and the development of targeted, mechanism-based active ingredients. This study highlights a novel cheminformatics-guided approach to discovering peptides that support collagen quality rather than simply boosting its synthesis. By screening a virtual library of 67 million peptides, researchers identified a […]

AI-Driven Design of Antiviral Peptides: A Hybrid Generative–Predictive Framework for Next-Generation Therapeutics

December 5, 2025

Abstract The increasing threat of viral pathogens and the limitations of existing antiviral therapeutics underscore the need for more efficient strategies to identify novel antiviral peptides (AVPs). This article examines a recently developed hybrid deep-learning framework that integrates generative modeling with predictive classification to accelerate AVP discovery. Using a Wasserstein GAN with Gradient Penalty (WGAN-GP), […]

Engineering the Future of Skincare: How Advanced Peptide Science Is Transforming Cosmetic R&D

November 28, 2025

Abstract Peptides have emerged as one of the most influential technology drivers in modern cosmetic research and development. Originally developed within pharmaceutical science, peptides now offer cosmetic formulators unparalleled precision in targeting biological pathways linked to aging, pigmentation, hydration, repair, and microbiome balance. Recent advances in synthesis—including SPPS, LPPS, enzymatic catalysis, and recombinant production—have significantly […]